Project Grant R35GM164085
- The National Institute of General Medical Sciences awarded the University of Missouri System (operating as Curators of the University of Missouri) $427,526 on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research into the functions and mechanisms of bacterial serine-threonine kinases. The research elucidates the fundamental role of post-translational protein modifications in bacterial cellular signaling, with emphasis on serine-threonine...
- The National Institute of General Medical Sciences awarded the University of Missouri System $418,822 on April 5, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to advance mechanistic understanding of membrane interfaces. The research addresses two primary areas: understanding the mechanism by which candidalysin, a peptide virulence factor secreted by Candida albicans, attacks host cell membranes by forming pores in lipid bilayers; and defining the mechanism of...
- The University of Missouri System was awarded a five-year, $759,888 Project Grant from the National Science Foundation Division of Molecular and Cellular Biosciences to conduct research on the biosynthesis of lipid monolayer membranes in bacteria. The grant falls under the Biological Sciences program (CFDA 47.074), which aims to promote progress in the biological sciences and strengthen the nation's scientific enterprise through increasing knowledge and understanding of major problems....
- The National Institute of General Medical Sciences awarded the University of Missouri System $418,114 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop orthogonal strategies for chemoselective peptide macrocyclization. The funded work develops two new chemical methods for cyclizing peptides: a sulfur(VI)-fluoride exchange (SUFEX)-mediated cyclization method selective for tyrosine and a light-mediated cyclization method selective for lysine....
- The National Institute of General Medical Sciences awarded the University of Missouri System $811,983 on July 1, 2026, to operate a trans-disciplinary basic biomedical science predoctoral training program under the Biomedical Research and Research Training program (CFDA 93.859). The University of Missouri-Columbia will deliver a T32 training program for predoctoral students across four integrated PhD programs: Biochemistry, Biological Sciences, Biological Engineering, and Translational...
- The National Institute of General Medical Sciences awarded the University of Missouri System $425,974 on March 1, 2026, to elucidate plant-derived steroidal biosynthetic pathways and develop sustainable bioproduction platforms for high-value pharmaceutical steroids under the Biomedical Research and Research Training program (CFDA 93.859). The recipient will identify and characterize biosynthetic enzymes that convert simple plant sterols to specialized steroids, including cardenolides and...
- The National Institute of General Medical Sciences awarded the University of Missouri System $429,797 on March 24, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct structure-function studies of apolipoprotein B100. The recipient will conduct biophysical research focused on understanding how apolipoprotein B (ApoB), one of the largest known proteins, functions in lipid transport and metabolism. The research uses state-of-the-art electron microscopy,...
- The National Institute of General Medical Sciences awarded Missouri University of Science & Technology $528,560 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the structure, catalytic mechanism, and inhibition of flavin-dependent N-monooxygenases, enzymes essential to siderophore biosynthesis in pathogenic bacteria and fungi. The project performs detailed biochemical and structural studies of histamine N-monooxygenases from...
- The National Institute of General Medical Sciences awarded the University of Missouri System $2.285 million on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop artificial intelligence methods for reconstructing protein complex structures from cryo-electron microscopy data and predicting mutated protein structures. The award funds research to address two key gaps in structural bioinformatics: the lack of automated, accurate methods for...
- The University of Missouri System was awarded a $790,842 Project Grant from the National Science Foundation Division of Molecular and Cellular Biosciences under the Biological Sciences federal grant program (CFDA 47.074). The grant will fund research from August 1, 2021 to July 31, 2025 to characterize interactions at the protein-lipid bilayer interface via single-molecule force spectroscopy techniques. The Biological Sciences program aims to advance biological knowledge and understanding...
The National Institute of General Medical Sciences awarded the University of Missouri System $364,623 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research dissecting the regulatory networks involved in elongation, division, and cell wall homeostasis in polarly growing bacteria. The project uses Agrobacterium tumefaciens as a model organism to determine the molecular mechanisms underlying polar growth and to understand the genetic determinants that govern polar cell-wall peptidoglycan biogenesis in coordination with the cell cycle and in response to dynamic environmental conditions. The research will systematically dissect the regulatory mechanisms that enable spatiotemporal coordination of peptidoglycan synthetic complexes with cell cycle progression and will explore how polarly growing bacteria respond to cell wall stress to maintain peptidoglycan homeostasis in harsh environments such as during host invasion. Work is performed in Columbia, Missouri. The period of performance runs from August 1, 2026, through April 30, 2031. The University of Missouri System, operating as the Curators of the University of Missouri, is the recipient. This is a Project Grant assistance type supporting basic research that increases understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $364.6k | 7/29/26 |